Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX) announced that the first two patients have been dosed in the EXACT Study, a Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE